ArticleActa obstetricia et gynecologica Scandinavica2026
Focusing on VaIN2+: Development and validation of a prediction nomogram based on a large colposcopy population.
Article in Acta obstetricia et gynecologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionVaginal intraepithelial neoplasia 2 or worse (VaIN2+) has long remained in a largely passive diagnostic pattern due to the lack of specific clinical manifestations and routine screening strategies. This study aimed to explore its clinical characteristics and develop a prediction model for individualized risk assessment. MATERIAL AND
methodsWe retrospectively analyzed the clinical characteristics and human papillomavirus (HPV) genotype distribution in 3259 women undergoing colposcopy at a single center between September 2012 and December 2024. A nomogram was developed based on predictors initially screened by least absolute shrinkage and selection operator regression and finalized through multivariable logistic regression. The model's discriminative ability, calibration, and clinical utility were assessed in both training and validation sets.
resultsAmong 1192 women with VaIN2+, older age, HPV infection, cytology worse than atypical squamous cells of undetermined significance (ASCUS), and concurrent cervical/vulvar lesions were more prevalent than in 2067 women without vaginal lesions. HPV16, HPV58, HPV52, HPV33, and HPV18 were the most common genotypes. A nomogram was developed based on 10 independent predictors identified by multivariable analysis, including age, hysterectomy history, specific HPV genotypes (16, 58, 56, 35, 39), cytological results (ASCUS and worse), concurrent cervical lesions (cervical intraepithelial neoplasia 1, cervical intraepithelial neoplasia 2 or 3, cervical squamous cell carcinoma), and concurrent vulvar lesions. The nomogram demonstrated good discrimination, with an area under the receiver operating characteristic curve of 0.771 in the training set and 0.791 in the validation set. Calibration was satisfactory, and decision curve analysis confirmed superior clinical net benefit across a wide threshold probability range.
conclusionsBy profiling VaIN2+ characteristics, this study developed the first prediction model integrating specific HPV genotypes with multiple clinical factors. This model enables clinicians to proactively identify high-risk individuals, thereby facilitating earlier diagnosis and intervention for VaIN2+.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.